- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
MYRG earnings call for the period ending June 30, 2021.
What happened Shares of several COVID-19 vaccine makers were sliding on Monday. BioNTech stock (NASDAQ: BNTX) was down 6.5% at 12:09 p.m. EDT. Shares of Moderna (NASDAQ: MRNA) had slipped 4.4%. Novavax (NASDAQ: NVAX) stock had fallen 6%.
Brian Sozzi, Julie Hyman, and Brian Cheung break down Monday’s trending tickers which include: Tesla shareholders receiving a recommendation to reject Kimbal Musk and Murdoch as board members, Morgan Stanley cutting Amazon’s price target as concerns over the company’s profitability take center stage, and Polestar partnering with Gores Guggenheim in a SPAC deal to go public.
Citigroup analyst P.J. Juvekar visited Plug Power recently and came away impressed with its plans to expand its hydrogen-gas-making capabilities.
Boeing stock is higher after U.S. durable-goods orders for August 2021 blew past economist expectations Monday.
In this article, we reviewed Bridgewater Associates founder Ray Dalio’s portfolio adjustment strategies to cope up with the market volatility. We also discussed the top ten stocks billionaire Ray Dalio is buying. You can skip our detailed discussion and jump directly to Billionaire Ray Dalio is Buying These 5 Stocks. Raymond Thomas Dalio’s $223 billion […]
Computer systems design services company Nvidia (NASDAQ: NVDA) stock has delivered impressive gains of more than 70% so far this year, beating rival Advanced Micro Devices (NASDAQ: AMD) handsomely as investors have appreciated the graphics card specialist's robust revenue and earnings growth. In this article, we will look at the catalysts driving AMD's growth and check what makes it a better bet than Nvidia right now. Video game consoles have been in hot demand since last year.
The Securities and Exchange Commission charged two traders with engaging in so-called "wash trading" of meme stocks, including GameStop, Inc. in alleged scheme that netted them hundreds of thousands of dollars in ill-gotten rebates from a number of stock brokers.
Red Cat Holdings Inc (NASDAQ: RCAT) is trading significantly higher Monday after the company announced its subsidiary, Skypersonic Inc, won a 5-year NASA contract. NASA is preparing a series of analog missions that will simulate year-long stays on the surface of Mars. The crew will conduct simulated operations by remote piloting Skypersonic drones and rovers in a simulated martian environment. Skypersonic's Dronebox real-time transoceanic remote piloting platform will drive the piloting of both
Biotech stocks have been some of the most reliable capital-appreciation vehicles in the entire market for the past two decades. As proof, biotech equities such as CRISPR Therapeutics, Moderna, Novavax, Ocugen, and Vertex Pharmaceuticals -- just to name a few -- have all made their early shareholders market-crushing gains. Not all biotech stocks are cut from the same cloth, however.
The next iPhone will bring the first complete redesign to the line-up in years, according to a new report. The iPhone 13 has only been in shops for less than a week, but rumours are already beginning about what form its successor will take. The new line-up will include “new entry-level and Pro models and a complete redesign”, according to Bloomberg’s Mark Gurman, who has a strong track record of detailing Apple products before they are announced to the public.
(Bloomberg) -- Polestar, the electric-vehicle maker backed by Volvo Car Group and actor Leonardo DiCaprio, agreed to go public through a merger with a blank-check company at a roughly $20 billion enterprise valuation.Most Read from BloombergHow Los Angeles Became the City of DingbatsWhy the Gaza Strip May Be the City of the FutureSchool Reopenings Falter as U.S. Kids Near 1 Million Covid CasesThe Rise of the Pandemic DashboardA Jewish Tradition Makes Room for Unconventional DesignThe automaker f
One stock investors may be considering is pot producer Sundial Growers (NASDAQ: SNDL). In the wake of that decline, is Sundial Growers a bargain worth buying, or should investors steer clear? Sundial Growers is no exception.
This trio, with yields ranging from 4.7% to 5.4%, should net Berkshire Hathaway over $635 million in annual dividend income.
The market's recent volatility may have you feeling skittish, but it has turned some good investing opportunities into even better deals.
The fascinating thing about General Electric (NYSE: GE), Johnson Controls (NYSE: JCI), and Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is that they have entirely different earnings drivers over the next decade. Former CEO Jeff Immelt has been widely criticized for making big bets on fossil fuel technologies. Unfortunately, the market for gas turbines halved in the years since the significant Alstom acquisition, as did the price of oil after Immelt made a slew of acquisitions.
Investors love healthcare stocks in both bull markets and times of uncertainty, but not all investments are slam-dunks. The following three healthcare-related stocks have a handful of specific characteristics that make them great candidates to fulfill different roles in your investment portfolio. CVS Health (NYSE: CVS) is a diverse healthcare company that operates a chain of drugstores, a pharmacy benefits management business, and a major health insurance carrier since its 2017 acquisition of Aetna.
These stocks are Dividend Kings for a reason, and they look really well poised to grow manifold in the coming years.
Shell is taking on the customers of collapsed energy company Green Supplier as the sector's crisis strengthens larger, more resilient players.
Dell Technologies (NYSE: DELL) shareholders are about to realize a corporate event they've been looking forward to for over a year now: the tax-free spinoff of Dell's 80.6% stake in virtualization software company VMware (NYSE: VMW). Dell's stock has already done quite well in 2021, up more than 40% on the year, in anticipation of the move. Last week, management held an analyst day, touting its outlook for the core business, as well as the future implementation of a large share repurchase plan and initiation of what looks to be a hefty future dividend.
With that in mind, we asked three Motley Fool contributors to highlight one stock that's already a tremendous run so far this year that they'd buy today. Danny Vena (Global-E Online): There's little doubt e-commerce has a long runway ahead. The company handles many of the challenges and complexities that come with international selling, leaving the merchant to go about their daily routine.